The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 391,865 | 1,346,660 | SH | SOLE | 1,346,660 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 37,093 | 1,650,780 | SH | SOLE | 1,650,780 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 43,178 | 1,356,514 | SH | SOLE | 1,356,514 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 23,493 | 1,849,832 | SH | SOLE | 1,849,832 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 126,601 | 1,135,845 | SH | SOLE | 1,135,845 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 54,924 | 218,707 | SH | SOLE | 218,707 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 3,104 | 3,013,793 | SH | SOLE | 3,013,793 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 67,317 | 3,340,806 | SH | SOLE | 3,340,806 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 92,463 | 6,147,829 | SH | SOLE | 6,147,829 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 206,362 | 2,545,482 | SH | SOLE | 2,545,482 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 33,823 | 379,140 | SH | SOLE | 379,140 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 208,859 | 3,955,660 | SH | SOLE | 3,955,660 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 891 | 123,686 | SH | SOLE | 123,686 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 4,789 | 500,913 | SH | SOLE | 500,913 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 122,388 | 6,895,075 | SH | SOLE | 6,895,075 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 12,612 | 312,719 | SH | SOLE | 312,719 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 13,261 | 175,900 | SH | SOLE | 175,900 | 0 | 0 | ||
HISTOGENICS CORP | COM | 43358V109 | 833 | 302,922 | SH | SOLE | 302,922 | 0 | 0 | ||
IDERA PHARMACEUTICALS INC | COM NEW | 45168K306 | 1,134 | 616,355 | SH | SOLE | 616,355 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 70,070 | 4,796,008 | SH | SOLE | 4,796,008 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 161,234 | 7,159,590 | SH | SOLE | 7,159,590 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 49,385 | 3,679,978 | SH | SOLE | 3,679,978 | 0 | 0 | ||
MELINTA THERAPEUTICS INC | COM | 58549G100 | 375 | 50,689 | SH | SOLE | 50,689 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 33,222 | 1,830,435 | SH | SOLE | 1,830,435 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 40,430 | 1,101,338 | SH | SOLE | 1,101,338 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 14,040 | 3,966,087 | SH | SOLE | 3,966,087 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 131,809 | 818,331 | SH | SOLE | 818,331 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 28,563 | 191,200 | SH | SOLE | 191,200 | 0 | 0 | ||
SOPHIRIS BIO INC | COM NEW | 83578Q209 | 496 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 52,028 | 3,515,385 | SH | SOLE | 3,515,385 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 3,162 | 1,162,473 | SH | SOLE | 1,162,473 | 0 | 0 | ||
TREVENA INC | COM | 89532E109 | 560 | 341,300 | SH | SOLE | 341,300 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 182,319 | 1,622,631 | SH | SOLE | 1,622,631 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 70,023 | 4,155,670 | SH | SOLE | 4,155,670 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 54,606 | 2,752,294 | SH | SOLE | 2,752,294 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,181 | 29,500 | SH | SOLE | 29,500 | 0 | 0 |